© 2021 MJH Life Sciences and Psychiatric Times. All rights reserved.
© 2021 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
December 07, 2020
As typically happens in the aftermath of suicide—years or even decades later—we wonder what we could have said or should have seen.
December 04, 2020
Are patients with depression and substance use disorder getting an appropriate level of care? Our Journal Club piece investigates.
December 02, 2020
The PHQ-9 may be an effective asset in a clinician’s toolkit, along with their clinical judgment and therapeutic alliance, to ensure treatment planning and outcome tracking is personal to each patient.
November 19, 2020
Physical activity and exercise are recognized as fundamental tools for reducing the impact of chronic diseases, including depression.
November 18, 2020
Facts and myths about depression during the holidays.
What issues do you anticipate your patients will struggle with during the upcoming holidays?
November 10, 2020
Patients' first reactions to a diagnosis of major depressive disorder can be varied. What can you do to help them cope?
November 09, 2020
Learn about REL-1017, the medication that has the potential to be the first single agent oral NMDAR antagonist for the adjunctive treatment of depression.
November 06, 2020
There are no human clinical trials or even case reports to assess or describe the efficacy of this very complex botanical. Here’s what we know.
November 04, 2020
The unique opportunities for clinicians in identifying risk and preventing suicide are discussed in this podcast.